BioTechnology

Remepy Raises $36M to Advance Hybrid Drugs Into Phase III

Modern medicine can be remarkably precise about what happens inside the body, yet much of what shapes recovery happens outside the pill. Movement, cognition, behavior and daily routines can influence how patients manage chronic disease, but those interventions often sit in separate programs, appointments and apps. Remepy is building around a different idea: what if […]